Related references
Note: Only part of the references are listed.Single intravenous high-dose sugammadex (up to 96 mg/kg) is generally safe and well tolerated in healthy volunteers
P. Peeters et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2013)
A Randomized, Dose-Response Study of Sugammadex Given for the Reversal of Deep Rocuronium- or Vecuronium-Induced Neuromuscular Blockade Under Sevoflurane Anesthesia
Philippe Duvaldestin et al.
ANESTHESIA AND ANALGESIA (2010)
Monitoring and Pharmacologic Reversal of a Nondepolarizing Neuromuscular Blockade Should Be Routine
Ronald D. Miller et al.
ANESTHESIA AND ANALGESIA (2010)
Sugammadex Provides Faster Reversal of Vecuronium-Induced Neuromuscular Blockade Compared with Neostigmine: A Multicenter, Randomized, Controlled Trial
Karin S. Khuenl-Brady et al.
ANESTHESIA AND ANALGESIA (2010)
Visionaries and Dreamers
Sorin J. Brull et al.
ANESTHESIA AND ANALGESIA (2010)
Rapid Chemical Antagonism of Neuromuscular Blockade by L-Cysteine Adduction to and Inactivation of the Olefinic (Double-bonded) Isoquinolinium Diester Compounds Gantacurium (AV430A), CW 002, and CW 011
John J. Savarese et al.
ANESTHESIOLOGY (2010)
Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study
L. M. Staals et al.
BRITISH JOURNAL OF ANAESTHESIA (2010)
Effects of Sugammadex Doses up to 32 mg/kg Alone or in Combination with Rocuronium or Vecuronium on QTc Prolongation A Thorough QTc Study
Pieter-Jan de Kam et al.
CLINICAL DRUG INVESTIGATION (2010)
Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial
Manfred Blobner et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2010)
Reversal of Profound, High-dose Rocuronium–induced Neuromuscular Blockade by Sugammadex at Two Different Time Points
Friedrich K. Pühringer et al.
ANESTHESIOLOGY (2009)
Reversal of Profound Neuromuscular Block by Sugammadex Administered Three Minutes after Rocuronium A Comparison with Spontaneous Recovery from Succinylcholine
Chingmuh Lee et al.
ANESTHESIOLOGY (2009)
Reversal of Neuromuscular Blockade by Sugammadex after Continuous Infusion of Rocuronium in Patients Randomized to Sevoflurane or Propofol Maintenance Anesthesia
Christopher Rex et al.
ANESTHESIOLOGY (2009)
Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery
Vegard Dahl et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2009)
Residual neuromuscular blockade and critical respiratory events in the Postanesthesia care unit
Glenn S. Murphy et al.
ANESTHESIA AND ANALGESIA (2008)
Reversal of Profound Rocuronium-induced Blockade with Sugammadex
R. Kevin Jones et al.
ANESTHESIOLOGY (2008)
Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers
G. Cammu et al.
BRITISH JOURNAL OF ANAESTHESIA (2008)
Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function
L. M. Staals et al.
BRITISH JOURNAL OF ANAESTHESIA (2008)
Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine
E. A. Flockton et al.
BRITISH JOURNAL OF ANAESTHESIA (2008)
Sugammadex: a novel selective relaxant binding agent
Mohamed Naguib et al.
Expert Review of Clinical Pharmacology (2008)
Cyclodextrin production by cyclodextrin glycosyltransferase from Bacillus circulans DF 9R
Natalia Szerman et al.
BIORESOURCE TECHNOLOGY (2007)
Prolonged residual paralysis after a single intubating dose of rocuronium
C. Claudius et al.
BRITISH JOURNAL OF ANAESTHESIA (2007)
Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex - A multicenter, dosefinding and safety study
Hans D. de Boer et al.
ANESTHESIOLOGY (2007)
Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study - Efficacy, safety, and pharmacokinetics
Harald J. Sparr et al.
ANESTHESIOLOGY (2007)
Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1)
A. L. Molina et al.
BRITISH JOURNAL OF ANAESTHESIA (2007)
Sugammadex reversal of rocuronium-induced neuromuscular blockade: A comparison with neostigmine-glycopyrrolate and edrophonium-atropine
Ozlem Sacan et al.
ANESTHESIA AND ANALGESIA (2007)
Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane
Bernard F. Vanacker et al.
ANESTHESIA AND ANALGESIA (2007)
Randomized, dose-finding, Phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block
Scott B. Groudine et al.
ANESTHESIA AND ANALGESIA (2007)
Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent
Koen Suy et al.
ANESTHESIOLOGY (2007)
Tactile fade detection with hand or wrist stimulation using train-of-four, double-burst stimulation, 50-Hertz tetanus, 100-Hertz tetanus, and acceleromyography
F Capron et al.
ANESTHESIA AND ANALGESIA (2006)
Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex - A dose-finding and safety study
IF Sorgenfrei et al.
ANESTHESIOLOGY (2006)
Comparison of phonomyography, kinemyography and mechanomyography for neuromuscular monitoring
G Trager et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2006)
Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys
HD de Boer et al.
BRITISH JOURNAL OF ANAESTHESIA (2006)
Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block
M Shields et al.
BRITISH JOURNAL OF ANAESTHESIA (2006)
Bronchospasm caused by neostigmine
A Hazizaj et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2006)
First human exposure of org 25969, a novel agent to reverse the action of rocuronium bromide
F Gijsenbergh et al.
ANESTHESIOLOGY (2005)
Antagonism of neuromuscular blockade but not muscle relaxation affects depth of anaesthesia
FC Vasella et al.
BRITISH JOURNAL OF ANAESTHESIA (2005)
Postanesthesia care unit recovery times and neuromuscular blocking drugs: A prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium
GS Murphy et al.
ANESTHESIA AND ANALGESIA (2004)
Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action
B Debaene et al.
ANESTHESIOLOGY (2003)
2-O-substituted cyclodextrins as reversal agents for the neuromuscular blocker rocuronium bromide
GJ Tarver et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: Synthesis and structure-activity relationships
JM Adam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans - Pharyngeal videoradiography and simultaneous manometry after atracurium
E Sundman et al.
ANESTHESIOLOGY (2000)
Share Paper
